Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ)

CNY 16.08

(-0.12%)

Market Cap (In CNY)

4.63 Billion

Revenue (In CNY)

663.02 Million

Net Income (In CNY)

176.11 Million

Avg. Volume

4.97 Million

Currency
CNY
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
13.63-25.77
PE
43.46
EPS
0.37
Beta Value
0.981
ISIN
CNE100005782
CUSIP
-
CIK
-
Shares
288000000.0
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals
CEO
Mr. Qun Liang
Employee Count
-
Website
https://biocause.com
Ipo Date
2021-12-22
Details
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.